Local vascular dysfunction after coronary paclitaxel-eluting stent implantation
Authors:
- Lorenz RäberLRLorenz Räber
- Rosangela CocchiaRCRosangela Cocchia
- Peter WenaweserPWPeter Wenaweser
- Stephane CookSCStephane Cook
- Stephan WindeckerSWStephan Windecker
- Bernhard MeierBMBernhard Meier
- Otto M. HessOHOtto M. Hess
- 1 August 2007
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 120 (2) , 212-220
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationNew England Journal of Medicine, 2005
- Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyThe Lancet, 2004
- One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS StentCirculation, 2004
- Vascular Responses at Proximal and Distal Edges of Paclitaxel-Eluting StentsCirculation, 2004
- Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary StentCirculation, 2004
- Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery LesionsCirculation, 2003
- Preliminary Observations Regarding Angiographic Pattern of Restenosis After Rapamycin-Eluting Stent ImplantationCirculation, 2003
- A Paclitaxel-Eluting Stent for the Prevention of Coronary RestenosisNew England Journal of Medicine, 2003
- TAXUS ICirculation, 2003
- Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat.Journal of Clinical Investigation, 1995